What tests should be ordered to evaluate for Toxoplasma gondii infection?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: November 20, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Testing for Toxoplasma gondii Infection

Order Toxoplasma IgG and IgM serology as the initial screening tests, but for pregnant women or neonates with suspected congenital toxoplasmosis, testing must be performed at a specialized toxoplasmosis reference laboratory, not at commercial laboratories. 1

Initial Screening Approach

For General Population and Pregnant Women

Start with Toxoplasma IgG and IgM antibody testing in peripheral blood 1. However, the critical distinction is where these tests are performed:

  • Commercial/hospital-based laboratories can be used for initial screening to identify seronegative (uninfected) versus seropositive patients 1
  • Reference laboratory testing is mandatory when:
    • IgM is positive or equivocal (approximately 60% of positive IgM results from commercial labs are false positives or represent chronic infection, not acute infection) 1
    • Pregnant women need confirmation of acute infection
    • Timing of infection needs to be determined

Key Testing Algorithm for Pregnant Women

If screening at commercial lab shows:

  • Negative IgG and IgM: Patient is seronegative and at risk for primary infection; no treatment needed unless immunocompromised 1
  • Positive IgG, negative IgM: Likely chronic infection acquired >3 months before conception; no treatment needed unless severely immunocompromised 1
  • Positive IgM (with or without IgG): Send to reference laboratory immediately for comprehensive panel 1

Reference Laboratory Testing (Essential for Accurate Diagnosis)

For pregnant women ≤16 weeks gestation, the reference lab panel includes 1:

  • Toxoplasma IgG dye test
  • Toxoplasma IgM ELISA
  • Toxoplasma IgG avidity test

For pregnant women >16 weeks, additional tests include 1:

  • Toxoplasma IgM ISAGA (more sensitive than ELISA)
  • Toxoplasma IgE ELISA
  • AC/HS differential agglutination test

Critical caveat: IgG avidity testing alone cannot differentiate acute from chronic infection, as low avidity can persist for years 1. A comprehensive panel is necessary.

Fetal Testing (When Maternal Infection Confirmed)

Amniocentesis for Toxoplasma PCR should be performed when 1, 2:

  • Maternal primary infection is diagnosed during pregnancy
  • Serologic testing cannot confirm or exclude acute infection
  • Ultrasound shows abnormalities (intracranial calcifications, microcephaly, hydrocephalus, ascites, hepatosplenomegaly, severe IUGR)

Timing requirements 2:

  • Perform at ≥18 weeks gestation
  • Wait ≥4 weeks after suspected maternal infection to reduce false negatives

Neonatal Testing (Suspected Congenital Toxoplasmosis)

All neonatal testing must be performed at a reference laboratory 1. Commercial lab testing is inadequate and cannot exclude congenital toxoplasmosis.

Initial neonatal workup includes 1:

  • Toxoplasma IgG dye test (tested in parallel with maternal IgG)
  • Toxoplasma IgM ISAGA (not ELISA—ELISA has poor sensitivity)
  • Toxoplasma IgA ELISA
  • Toxoplasma PCR on blood, urine, and CSF when high suspicion exists

Timing considerations for antibody testing 1:

  • Repeat IgM testing ≥5 days after birth if maternal blood contamination suspected (IgM half-life = 5 days)
  • Repeat IgA testing ≥10 days after birth if contamination suspected (IgA half-life = 10 days)
  • Wait ≥7 days after blood transfusion or IVIG before testing

CSF Toxoplasma PCR is indicated when 1:

  1. Infant has positive IgM ISAGA and/or IgA ELISA
  2. Mother had confirmed acute infection with positive amniotic fluid PCR or abnormal fetal ultrasound
  3. Mother had confirmed infection in 2nd or 3rd trimester without antepartum treatment

Special Populations

Immunocompromised patients (HIV, transplant, targeted immunotherapies) 3, 4:

  • Obtain baseline IgG and IgM serology before starting immunosuppression
  • Note that B-cell depletion may render IgG unreliable
  • Consider prophylaxis with trimethoprim-sulfamethoxazole for seropositive patients
  • Use PCR or metagenomic sequencing for diagnosis when serology is unreliable

Common Pitfalls to Avoid

  1. Never rely on negative IgM ELISA from commercial labs to exclude congenital toxoplasmosis—the IgM ISAGA test at reference labs is far more sensitive 1

  2. Do not interpret positive IgM as acute infection without confirmatory testing—IgM can persist for >1 year in chronic infection and has high false-positive rates 1

  3. Do not perform amniocentesis before 18 weeks or within 4 weeks of suspected maternal infection—this increases false-negative results 2

  4. Always test neonatal and maternal IgG in parallel—interpretation of neonatal results is unreliable without maternal comparison 1

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.